Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain

Inflammation Research

Volumn 59, Issue 9, 2010, Pages 679-687

  Shigetomi, Hiroshi ^a   Onogi, Akira ^a   Kajiwara, Hirotaka ^a   Yoshida, Shozo ^a   Furukawa, Naoto ^a   Haruta, Shoji ^a   Tanase, Yasuhito ^a   Kanayama, Seiji ^a   Noguchi, Taketoshi ^a   Yamada, Yoshihiko ^a   Oi, Hidekazu ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Inflammation; Kunitz; Protease inhibitor; Tissue remodeling

Indexed keywords

APROTININ; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR; HYALURONIC ACID; INTER ALPHA TRYPSIN INHIBITOR; PENTRAXIN 3; SERINE PROTEINASE INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; ULINASTATIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ACUTE PANCREATITIS; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; BURN; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; EVIDENCE BASED MEDICINE; EXTRACELLULAR MATRIX; GENE TARGETING; HUMAN; INFLAMMATION; MEDLINE; METASTASIS; NONHUMAN; POSTOPERATIVE HEMORRHAGE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SOLID TUMOR; STRUCTURE ACTIVITY RELATION; THROMBOCYTE DYSFUNCTION; TISSUE INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; MICE; SERINE PROTEINASE INHIBITORS;

EID: 77955657837     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0205-5     Document Type: Review

References (84)

1. RM Roberts N Mathialagan JY Duffy GW Smith 1995 Regulation and regulatory role of proteinase inhibitors Crit Rev Eukaryot Gene Expr 5 385 436 1:CAS:528:DyaK28Xhs1yhtbs%3D 8834232
2. M Ferencík V Stvrtinová I Hulín M Novák 2007 Inflammation-a lifelong companion: attempt at a non-analytical holistic view Folia Microbiol (Praha) 52 159 173 10.1007/BF02932155
3. H Kobayashi M Suzuki Y Hirashima T Terao 2003 The protease inhibitor bikunin, a novel anti-metastatic agent Biol Chem 384 749 754 10.1515/BC.2003.083 1:CAS:528:DC%2BD3sXks1Kiu7g%3D 12817471
4. JP Vincent M Lazdunski 1972 Trypsin-pancreatic trypsin inhibitor association: dynamics of the interaction and role of disulfide bridges Biochemistry 11 2967 2977 10.1021/bi00766a007 1:STN:280:DyaE383jtVSktg%3D%3D 5041905
5. T Astrup U Nissen 1964 Urinary trypsin inhibitor (Mingin): transformation into a new trypsin inhibitor by acid hydrolysis or by sialidase Nature 203 255 257 10.1038/203255a0 1:CAS:528:DyaF2cXksV2it74%3D 14201757
6. T Shimomura K Denda A Kitamura T Kawaguchi M Kito J Kondo S Kagaya L Qin H Takata K Miyazawa N Kitamura 1997 Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor J Biol Chem 272 6370 6376 10.1074/jbc.272.10.6370 1:CAS:528:DyaK2sXhvVOlt78%3D 9045658
7. HT Salem BC Obiekwe AT Al-Ani M Seppälä T Chard 1980 Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer Clin Chim Acta 107 211 215 10.1016/0009-8981(80)90448-9 1:CAS:528:DyaL3MXisFWq 7438456
8. P Ascenzi A Bocedi M Bolognesi A Spallarossa M Coletta R De Cristofaro E Menegatti 2003 The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein Curr Protein Pept Sci 4 231 251 10.2174/1389203033487180 1:CAS:528:DC%2BD3sXjvV2ht7o%3D 12769721
9. JR Day RC Landis KM Taylor 2006 Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction Semin Cardiothorac Vasc Anesth 10 132 142 10.1177/1089253206288997 1:STN:280:DC%2BD28rjsFOrtQ%3D%3D 16959740
10. A Rattenholl M Steinhoff 2008 Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease Drug News Perspect 21 369 381 10.1358/dnp.2008.21.7.1255294 1:CAS:528: DC%2BD1cXhsVOgurnJ 19259550
11. PF Mercer X Deng RC Chambers 2007 Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury Ann N Y Acad Sci 1096 86 88 10.1196/annals.1397. 073 1:CAS:528:DC%2BD2sXkslCjs7o%3D 17405919
12. JL Kristeller BP Roslund RF Stahl 2008 Benefits and risks of aprotinin use during cardiac surgery Pharmacotherapy 28 112 124 10.1592/phco.28.1.112 1:CAS:528:DC%2BD1cXhtlegsrY%3D 18154481
13. W Dietrich 2004 Efficacy and safety of aprotinin in cardiac surgery Orthopedics 27 s659 s662
14. M Bosman D Royston 2008 Aprotinin and renal dysfunction Expert Opin Drug Saf 7 663 677 10.1517/14740330802510717 1:CAS:528:DC%2BD1cXhtlaisrfK 18983214
15. + channel by peptidases Curr Top Dev Biol 78 23 46 10.1016/S0070-2153(06)78002-4 17338914
16. H He W Li DY Tseng S Zhang SY Chen AJ Day SC Tseng 2009 Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane J Biol Chem 284 20136 20146 10.1074/jbc.M109.021881 1:CAS:528:DC%2BD1MXos1ens7s%3D 19491101
17. M Yoneda S Suzuki K Kimata 1990 Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein J Biol Chem 265 5247 5257 1:CAS:528:DyaK3cXitFCiuro%3D 1690737
18. JP Salier P Rouet G Raguenez M Daveau 1996 The inter-alpha-inhibitor family: from structure to regulation Biochem J 315 1 9 1:CAS:528: DyaK28Xitlygsb4%3D 8670091
19. L Chen SJ Mao LR McLean RW Powers WJ Larsen 1994 Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid J Biol Chem 269 28282 28287 1:CAS:528:DyaK2cXmsVyktL0%3D 7525572
20. GB Menezes EF McAvoy P Kubes 2009 Hyaluronan, platelets, and monocytes: a novel pro-inflammatory triad Am J Pathol 174 1993 1995 10.2353/ajpath.2009. 081138 1:CAS:528:DC%2BD1MXmvFOqtbY%3D 19435789
21. D Jiang J Liang PW Noble 2007 Hyaluronan in tissue injury and repair Annu Rev Cell Dev Biol 23 435 461 10.1146/annurev.cellbio.23.090506.123337 1:CAS:528:DC%2BD2sXhtlartr3F 17506690
22. L Zhuo VC Hascall K Kimata 2004 Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex J Biol Chem. 279 38079 38082 10.1074/jbc.R300039200 1:CAS:528:DC%2BD2cXnt1Oqs7g%3D 15151994
23. R Forteza SM Casalino-Matsuda ME Monzon E Fries MS Rugg CM Milner AJ Day 2007 TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release Am J Respir Cell Mol Biol 36 20 31 10.1165/rcmb.2006-0018OC 1:CAS:528:DC%2BD2sXhtFSls7Y%3D 16873769
24. CM Milner VA Higman AJ Day 2006 TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 34 446 450 10.1042/BST0341261 1:CAS:528: DC%2BD28XkvVGitb8%3D 16709183
25. MS Rugg AC Willis D Mukhopadhyay VC Hascall E Fries C Fülöp CM Milner AJ Day 2005 Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan J Biol Chem. 280 25674 25686 10.1074/jbc.M501332200 1:CAS:528:DC%2BD2MXlslyksrs%3D 15840581
26. S Garantziotis JW Hollingsworth RB Ghanayem S Timberlake L Zhuo SJ Getting DJ Mahoney T Cao MS Rugg E Fries CM Milner M Perretti AJ Day 2002 The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner J Biol Chem 277 51068 51076 10.1074/jbc.M205121200
27. A Kehlen A Pachnio K Thiele J Langner 2003 Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6 Arthritis Res Ther. 5 R186 R192 10.1186/ar762 1:CAS:528:DC%2BD3sXjvVGhsbo%3D 12823853
28. A Agrawal PP Singh B Bottazzi C Garlanda A Mantovani 2009 Pattern recognition by pentraxins Adv Exp Med Biol 653 98 116 10.1007/978-1-4419-0901-5- 7 19799114
29. GW Lee TH Lee J Vilcek 1993 TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins J Immunol 150 1804 1812 1:CAS:528:DyaK3sXltFGju7w%3D 7679696
30. L Scarchilli A Camaioni B Bottazzi V Negri A Doni L Deban A Bastone G Salvatori A Mantovani G Siracusa A Salustri 2007 PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion J Biol Chem. 282 30161 30170 10.1074/jbc.M703738200 1:CAS:528:DC%2BD2sXhtFagtbbL 17675295
31. DG Souza FA Amaral CT Fagundes FM Coelho RM Arantes LP Sousa MM Matzuk C Garlanda A Mantovani AA Dias MM Teixeira 2009 The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice Am J Pathol 174 1309 1318 10.2353/ajpath.2009.080240 1:CAS:528:DC%2BD1MXksVOktL4%3D 19286566
32. JE Adair V Stober M Sobhany L Zhuo JD Roberts M Negishi K Kimata S Garantziotis 2009 Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin binding J Biol Chem. 284 16922 16930 10.1074/jbc.M808560200 1:CAS:528:DC%2BD1MXntFCjtr4%3D 19395377
33. TE Jessen L Odum AH Johnsen 1994 In vivo binding of human inter-alpha-trypsin inhibitor free heavy chains to hyaluronic acid Biol Chem Hoppe-Seyler 375 521 526 1:CAS:528:DyaK2MXntlensw%3D%3D 7529027
34. W Selbi AJ Day MS Rugg C Fülöp CA de la Motte T Bowen VC Hascall AO Phillips 2006 Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells J Am Soc Nephrol 17 1553 1567 10.1681/ASN.2005080879 1:CAS:528:DC%2BD28XlvVemurw%3D 16687630
35. J Hinshelwood DI Spencer YJ Edwards SJ Perkins 1999 Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionization affinity mass spectrometry and homology modelling: implications for the activity of factor B J Mol Biol 294 587 599 10.1006/jmbi.1999.3223 1:CAS:528:DyaK1MXotFekurk%3D 10610782
36. SA Boackle 2003 Complement and autoimmunity Biomed Pharmacother 57 269 273 10.1016/S0753-3322(03)00084-2 1:CAS:528:DC%2BD3sXnt1GntLs%3D 14499171
37. A Hamm J Veeck N Bektas PJ Wild A Hartmann U Heindrichs G Kristiansen T Werbowetski-Ogilvie R Del Maestro R Knuechel E Dahl 2008 Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysi BMC Cancer 8 25 10.1186/1471-2407-8-25 18226209
38. R Wu X Cui YP Lim K Bendelja M Zhou HH Simms P Wang 2004 Delayed administration of human inter-alpha inhibitor proteins reduces mortality in sepsis Crit Care Med 32 1747 1752 10.1097/01.CCM.0000132903.14121.0E 1:CAS:528:DC%2BD2cXmtFCgtb4%3D 15286553
39. S Yang YP Lim M Zhou P Salvemini H Schwinn D Josic DJ Koo IH Chaudry P Wang 2002 Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis Crit Care Med 30 617 622 10.1097/00003246-200203000-00021 1:CAS:528:DC%2BD38XislSmsrg%3D 11990925
40. E Wachter K Hochstrasser 1981 Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography Hoppe Seylers Z Physiol Chem. 362 1351 1355 1:CAS:528: DyaL38XkvVWntg%3D%3D 6171496
41. E Fries AM Blom 2000 Bikunin-not just a plasma proteinase inhibitor Int J Biochem Cell Biol 32 125 137 10.1016/S1357-2725(99)00125-9 1:CAS:528: DyaK1MXnvFeis7w%3D 10687949
42. E Yoshida H Sumi H Tsushima M Maruyama H Mihara 1991 Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study Inflammation 15 71 79 10.1007/BF00917911 1:CAS:528:DyaK3MXitVCiu7Y%3D 1711513
43. Y Yoshihara A Plaas B Osborn A Margulis F Nelson M Stewart MS Rugg CM Milner AJ Day K Nemoto JD Sandy 2008 Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin Osteoarthritis Cartilage 16 1343 1355 10.1016/j.joca.2008.04.004 1:STN:280:DC%2BD1cnntlCntw%3D%3D 18524635
44. H Itoh M Tomita T Kobayashi H Uchino H Maruyama Y Nawa 1996 Expression of inter-alpha-trypsin inhibitor light chain (bikunin) in human pancreas J Biochem 120 271 275 1:CAS:528:DyaK28XmtVOku7c%3D 8889810
45. SD Lin Y Takikawa R Endo K Suzuki 2004 Proinflammatory cytokines up-regulate synthesis and secretion of urinary trypsin inhibitor in human hepatoma HepG2 cells Hepatol Res. 29 243 248 10.1016/j.hepres.2004.04.003 1:CAS:528:DC%2BD2cXmt1Ont74%3D 15288018
46. K Imada A Ito N Kanayama T Terao Y Mori 1997 Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/proMMP-1 and prostromelysin 1/proMMP-3 in human uterine cervical fibroblasts and chorionic cells FEBS Lett. 417 337 340 10.1016/S0014-5793(97)01319-7 1:CAS:528: DyaK2sXnt1ektbo%3D 9409746
47. M Zaitsu Y Hamasaki K Tashiro M Matsuo T Ichimaru I Fujita H Tasaki S Miyazaki 2000 Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease J Infect Dis 181 1101 1109 10.1086/315332 1:CAS:528:DC%2BD3cXivVOnsr8%3D 10720537
48. H Kobayashi M Suzuki GW Sun Y Hirashima T Terao 2000 Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor Biochim Biophys Acta 1481 310 316 1:CAS:528:DC%2BD3cXmvFyqt7g%3D 11018722
49. Y Yamaguchi H Ohshiro Y Nagao K Odawara K Okabe H Hidaka K Ishihara S Uchino T Furuhashi S Yamada K Mori M Ogawa 2000 Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion J Surg Res 94 107 115 10.1006/jsre.2000.5999 1:CAS:528:DC%2BD3cXosVOmtLk%3D 11104650
50. S Aosasa S Ono H Mochizuki H Tsujimoto C Ueno A Matsumoto 2001 Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes Shock 15 101 105 10.1097/00024382-200115020-00004 1:STN:280:DC%2BD3M3isVamuw%3D%3D 11220636
51. P Molor-Erdene K Okajima H Isobe M Uchiba N Harada H Okabe 2005 Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression Am J Physiol Heart Circ Physiol. 288 H1265 H1271 10.1152/ajpheart.00885.2004 1:CAS:528:DC%2BD2MXisVOjsro%3D 15539418
52. P Molor-Erdene K Okajima H Isobe M Uchiba N Harada N Shimozawa H Okabe 2005 Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo Thromb Haemost 94 136 145 1:CAS:528:DC%2BD2MXms12ksL4%3D 16113797
53. YJ Wu Q Ling XH Zhou Y Wang HY Xie JR Yu SS Zheng 2009 Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation Hepatobiliary Pancreat Dis Int. 8 53 58 1:CAS:528:DC%2BD1MXjtFGgtL8%3D 19208516
54. K Wakahara H Kobayashi T Yagyu H Matsuzaki T Kondo N Kurita H Sekino K Inagaki M Suzuki N Kanayama T Terao 2005 Bikunin suppresses lipopolysaccharide- induced lethality through down-regulation of tumor necrosis factor- alpha and interleukin-1 beta in macrophages J Infect Dis 191 930 938 10.1086/428134 1:CAS:528:DC%2BD2MXivVygsro%3D 15717269
55. M Suzuki H Kobayashi Y Tanaka Y Hirashima N Kanayama Y Takei Y Saga M Suzuki H Itoh T Terao 2003 Bikunin target genes in ovarian cancer cells identified by microarray analysis J Biol Chem. 278 14640 14646 10.1074/jbc.M300239200 1:CAS:528:DC%2BD3sXjtVCmt7Y%3D 12571229
56. N Kanayama K Maehara L She HM Belayet S Khatun N Tokunaga T Terao 1998 Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca2 + influx Biochim Biophys Acta 1381 139 146 1:CAS:528:DyaK1cXks1Krs7k%3D 9685617
57. S Kanayama Y Yamada A Onogi H Shigetomi S Ueda Y Tsuji S Haruta R Kawaguchi S Yoshida M Sakata T Sado T Kitanaka H Oi T Yagyu H Kobayashi 2007 Bikunin suppresses expression of pro-inflammatory cytokines induced by lipopolysaccharide in neutrophils J Endotoxin Res. 13 369 376 10.1177/0968051907086464 1:CAS:528:DC%2BD1cXhvF2gtL4%3D 18182464
58. JR Yu S Yan XS Liu YJ Wu PF Fu LH Wu SS Zheng 2005 Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation World J Gastroenterol 11 1605 1609 1:CAS:528: DC%2BD2MXjvFOrtb4%3D 15786535
59. K Inoue H Takano R Yanagisawa M Sakurai A Shimada S Yoshino H Sato T Yoshikawa 2005 Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide Exp Biol Med. (Maywood) 230 281 287 1:CAS:528:DC%2BD2MXjtFequrc%3D
60. LW Zhou YL Wang XT Yan XH He 2008 Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model Saudi Med J 29 368 373 18327361
61. E El Maradny N Kanayama A Halim K Maehara T Kobayashi T Terao 1996 Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries Gynecol Obstet Invest 41 96 102 10.1159/000292051 1:STN:280:DyaK28vjs1SrsA%3D%3D 8838968
62. MJ Pugia R Valdes Jr SA Jortani 2007 Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement Adv Clin Chem 44 223 245 10.1016/S0065-2423(07)44007-0 1:CAS:528:DC%2BD1cXht1WltLs%3D 17682344
63. JM Rakic C Maillard M Jost K Bajou V Masson L Devy V Lambert JM Foidart A Noel 2003 Role of plasminogen activator-plasmin system in tumor angiogenesis Cell Mol Life Sci 60 463 473 10.1007/s000180300039 1:CAS:528: DC%2BD3sXjsFGit7g%3D 12737307
64. T Yagyu H Kobayashi H Matsuzaki K Wakahara T Kondo N Kurita H Sekino K Inagaki 2006 Enhanced spontaneous metastasis in bikunin-deficient mice Int J Cancer 118 2322 2328 10.1002/ijc.21293 1:CAS:528:DC%2BD28XjsVCgtLs%3D 16331631
65. KH Tsui PL Chang TH Feng LC Chung SY Hsu HH Juang 2008 Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells Anticancer Res 28 1977 1983 1:CAS:528:DC%2BD1cXhtVeksLrM 18649735
66. J Liu Q Guo B Chen Y Yu H Lu YY Li 2006 Cathepsin B and its interacting proteins, bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90 FEBS Lett. 580 245 250 10.1016/j.febslet.2005.12.005 1:CAS:528:DC%2BD28Xkslyh 16364318
67. C Parr WG Jiang 2006 Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells Int J Cancer 119 1176 1183 10.1002/ijc.21881 1:CAS:528:DC%2BD28Xns1Cmsbg%3D 16557597
68. D Kirchhofer M Peek W Li J Stamos C Eigenbrot S Kadkhodayan JM Elliott RT Corpuz RA Lazarus P Moran 2003 Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1 J Biol Chem. 278 36341 36349 10.1074/jbc.M304643200 1:CAS:528:DC%2BD3sXnt1ejs7k%3D 12815039
69. K Denda T Shimomura T Kawaguchi K Miyazawa N Kitamura 2002 Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1 J Biol Chem. 277 14053 14059 10.1074/jbc.M112263200 1:CAS:528:DC%2BD38XjsFWnt7o%3D 11805118
70. H Itoh H Kataoka JY Meng R Hamasuna N Kitamura M Koono 2001 Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters Biochim Biophys Acta 1519 92 95 1:CAS:528:DC%2BD3MXkt1Kktbk%3D 11406276
71. MR Morris D Gentle M Abdulrahman EN Maina K Gupta RE Banks MS Wiesener T Kishida M Yao B The F Latif ER Maher 2005 Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma Cancer Res 65 4598 4606 10.1158/0008-5472.CAN-04-3371 1:CAS:528:DC%2BD2MXks1OhtL0%3D 15930277
72. H Tanaka T Fukushima K Yorita M Kawaguchi H Kataoka 2009 Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells Hum Cell 22 11 17 19222607
73. R Szabo A Molinolo K List TH Bugge 2007 Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development Oncogene 26 1546 1556 10.1038/sj.onc.1209966 1:CAS:528: DC%2BD2sXisFynsbY%3D 16983341
74. AX Torres-Collado W Kisiel ML Iruela-Arispe JC Rodríguez- Manzaneque 2006 ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2 J Biol Chem. 281 17827 17837 10.1074/jbc.M513465200 1:CAS:528:DC%2BD28XmtFyktrw%3D 16641089
75. HS Chand DC Foster W Kisiel 2005 Structure, function and biology of tissue factor pathway inhibitor-2 Thromb Haemost 94 1122 1130 1:CAS:528:DC%2BD28Xms1OqtQ%3D%3D 16411383
76. AE Schmidt HS Chand D Cascio W Kisiel SP Bajaj 2005 Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition J Biol Chem 280 27832 27838 10.1074/jbc.M504105200 1:CAS:528:DC%2BD2MXmsVyqtbY%3D 15932872
77. JT Crawley DA Lane 2008 The haemostatic role of tissue factor pathway inhibitor Arterioscler Thromb Vasc Biol 28 233 242 10.1161/ATVBAHA.107.141606 1:CAS:528:DC%2BD1cXosVyitw%3D%3D 17951326
78. H Kato 2002 Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects Arterioscler Thromb Vasc Biol 22 539 548 10.1161/01.ATV.0000013904.40673.CC 1:CAS:528: DC%2BD38XjtVOrurw%3D 11950688
79. N Lanir A Aharon B Brenner 2003 Procoagulant and anticoagulant mechanisms in human placenta Semin Thromb Hemost 29 175 184 10.1055/s-2003-38833 1:CAS:528:DC%2BD3sXjsl2gt74%3D 12709921
80. H Guo Y Lin H Zhang J Liu N Zhang Y Li D Kong Q Tang D Ma 2007 Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells BMC Mol Biol. 8 110 10.1186/1471-2199-8-110 18053161
81. YY Liu SM Stack SS Lakka AJ Khan DT Woodley JS Rao CN Rao 1999 Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin Arch Biochem Biophys 370 8 112 10.1006/abbi.1999.1371
82. YF Lin N Zhang HS Guo DS Kong T Jiang W Liang ZH Zhao QQ Tang D Ma 2007 Recombinant tissue factor pathway inhibitor induces apoptosis in cultured rat mesangial cells via its Kunitz-3 domain and C-terminal through inhibiting PI3-kinase/Akt pathway Apoptosis 12 2163 2173 10.1007/s10495-007-0136-y 1:CAS:528:DC%2BD2sXht1Oksr3N 17885802
83. L Ivanciu RD Gerard H Tang F Lupu C Lupu 2007 Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis Arterioscler Thromb Vasc Biol 27 310 316 10.1161/01.ATV.0000254147.89321.cf 1:CAS:528:DC%2BD2sXjvFKhsg%3D%3D 17138934
84. BA Lwaleed PS Bass 2006 Tissue factor pathway inhibitor: structure, biology and involvement in disease J Pathol 208 327 339 10.1002/path.1871 1:CAS:528:DC%2BD28XhvFOntb4%3D 16261634